Efficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein Thrombosis
Status:
Recruiting
Trial end date:
2022-05-31
Target enrollment:
Participant gender:
Summary
A randomized controlled trial to study the efficacy and safety of Dabigatran in Cirrhotic
patients who develop PVT.In this study the patients who meet the inclusion criteria will be
randomized to either receive Dabigatran or placebo [multivitamin tablet]. Blood samples will
be taken &Imaging will be done accordingly to notice progression or recanalization of PVT.The
patients are followed up every 2 months up to 18 month .Then statistical analysis will be
done to find whether the Dabigatran is efficacious in cirrhotic patients for recanalization
of PVT.